Zai Lab (ZLAB) Cash & Current Investments (2016 - 2026)
Zai Lab's (ZLAB) quarterly Cash & Current Investments came in at $101.2 million in Q1 2026, little changed year-on-year from $101.2 million in Q1 2025, and down 87.02% quarter-over-quarter from $779.6 million in Q4 2025.
Zai Lab (ZLAB) Cash & Current Investments (2016 - 2026) Analysis & Trends
Zai Lab has disclosed Cash & Current Investments across 11 years of filings, most recently posting $101.2 million for Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $101.2 million, changed 0.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $101.2 million (changed 0.05% YoY), and the FY2025 annual result was $779.6 million, up 135.41% from the prior year.
- Cash & Current Investments came in at $101.2 million for Q1 2026 at Zai Lab, down from $779.6 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $1.3 billion in Q1 2022 to a low of $1.1 million in Q1 2024.
- The 5-year median for Cash & Current Investments is $331.2 million (2024), against an average of $508.9 million.
- Peak annual rise in Cash & Current Investments reached 8982.05% in 2025, while the deepest fall reached 98.81% in 2025.
- Zai Lab's Cash & Current Investments stood at $1.0 billion in 2022, then plunged by 98.27% to $17.4 million in 2023, then soared by 1803.21% to $331.2 million in 2024, then jumped by 135.41% to $779.6 million in 2025, then sank by 87.02% to $101.2 million in 2026.
- The last three Cash & Current Investments figures came in at $101.2 million (Q1 2026), $779.6 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 101.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.22 Mn |
| Dec 31, 2025 | 779.57 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 832.27 Mn |
| Mar 31, 2025 | 101.17 Mn |
| Dec 31, 2024 | 331.16 Mn |
| Sep 30, 2024 | 101.15 Mn |
| Jun 30, 2024 | 730.05 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 17.40 Mn |
| Sep 30, 2023 | 32.68 Mn |
| Jun 30, 2023 | 874.66 Mn |
| Mar 31, 2023 | 51.61 Mn |
| Dec 31, 2022 | 1.01 Bn |
| Sep 30, 2022 | 1.12 Bn |
| Jun 30, 2022 | 1.26 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.41 Bn |
| Sep 30, 2021 | 1.57 Bn |
| Jun 30, 2021 | 1.77 Bn |